Mogy Joel R Investment Counsel’s Gilead Sciences GILD Stock Holding History

Mogy Joel R Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-58,455	Closed	-$4.63M	–	126
2016 Q3	$4.63M	Sell	58,455 -12,200	-17%	-$991K	0.85%	36
2016 Q2	$5.89M	Sell	70,655 -2,695	-4%	-$239K	1.09%	33
2016 Q1	$6.74M	Buy	73,350 +66,104	+912%	+$5.96M	1.25%	29
2015 Q4	$7.33K	Sell	7,246 -59,844	-89%	-$6.23M	1.38%	28
2015 Q3	$6.59M	Buy	67,090 +11,535	+21%	+$1.28M	1.3%	26
2015 Q2	$6.5M	Buy	55,555 +19,655	+55%	+$2.15M	1.23%	27
2015 Q1	$3.52M	Buy	35,900 +10,840	+43%	+$1.1M	0.66%	46
2014 Q4	$2.36M	Buy	25,060 +15,895	+173%	+$1.64M	0.45%	57
2014 Q3	$976K	Buy	9,165 +4,350	+90%	+$426K	0.2%	80
2014 Q2	$399K	Buy	+4,815	New	+$375K	0.08%	116

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mogy Joel R Investment Counsel's GILD Position: Q4 2016 in Review

Mogy Joel R Investment Counsel sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 58,455 shares — an estimated $4.63M sold.

Mogy Joel R Investment Counsel first reported a position in GILD in Q2 2014 and held it in 10 quarters. The position peaked at $6.74M in Q1 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Mogy Joel R Investment Counsel reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Mogy Joel R Investment Counsel sold 58,455 Gilead Sciences shares in Q4 2016, an estimated $4.63M.
Mogy Joel R Investment Counsel first reported a position in Gilead Sciences in Q2 2014 and held it in 10 quarters.
Mogy Joel R Investment Counsel's Gilead Sciences position peaked at $6.74M in Q1 2016.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Mogy Joel R Investment Counsel's 13F filing for Q4 2016, filed 14 Feb 2017.